The Quarterly Brief –International Valuation Newsletter discusses current topics of busisness valuation.
Focus of the latest edition is on insights into the value drivers of pharmaceutical and biotechnology companies, with a particular focus on vaccine developers.
The following issues are emphasized: Sub sectors, economic factors, valuation approaches, uncertainty/COVID-19, and in addition key capital market data, i.e. for Austria and for BRICS countries.
